These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 3828993
1. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells. Taetle R, Honeysett JM. Cancer Res; 1987 Apr 15; 47(8):2040-4. PubMed ID: 3828993 [Abstract] [Full Text] [Related]
2. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Taetle R, Castagnola J, Mendelsohn J. Cancer Res; 1986 Apr 15; 46(4 Pt 1):1759-63. PubMed ID: 3004704 [Abstract] [Full Text] [Related]
3. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. White S, Taetle R, Seligman PA, Rutherford M, Trowbridge IS. Cancer Res; 1990 Oct 01; 50(19):6295-301. PubMed ID: 2400993 [Abstract] [Full Text] [Related]
4. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells. Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, Ohsugi Y. Clin Cancer Res; 1996 Feb 01; 2(2):253-9. PubMed ID: 9816167 [Abstract] [Full Text] [Related]
5. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells. Castagnola J, MacLeod C, Sunada H, Mendelsohn J, Taetle R. J Cell Physiol; 1987 Sep 01; 132(3):492-500. PubMed ID: 3498729 [Abstract] [Full Text] [Related]
6. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors. Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E. Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771 [Abstract] [Full Text] [Related]
7. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6. Brooks D, Taylor C, Dos Santos B, Linden H, Houghton A, Hecht TT, Kornfeld S, Taetle R. Clin Cancer Res; 1995 Nov 15; 1(11):1259-65. PubMed ID: 9815920 [Abstract] [Full Text] [Related]
8. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas. Crépin R, Goenaga AL, Jullienne B, Bougherara H, Legay C, Benihoud K, Marks JD, Poul MA. Cancer Res; 2010 Jul 01; 70(13):5497-506. PubMed ID: 20530676 [Abstract] [Full Text] [Related]
9. Comparative studies of the binding and growth-supportive ability of mammalian transferrins in human cells. Penhallow RC, Brown-Mason A, Woodworth RC. J Cell Physiol; 1986 Aug 01; 128(2):251-60. PubMed ID: 3015988 [Abstract] [Full Text] [Related]
10. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody. Taetle R, Rhyner K, Castagnola J, To D, Mendelsohn J. J Clin Invest; 1985 Mar 01; 75(3):1061-7. PubMed ID: 2984253 [Abstract] [Full Text] [Related]
11. The role of transferrin receptors in hemopoietic cell growth. Taetle R. Exp Hematol; 1990 May 01; 18(4):360-5. PubMed ID: 2182335 [Abstract] [Full Text] [Related]
12. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia. Sauvage CA, Mendelsohn JC, Lesley JF, Trowbridge IS. Cancer Res; 1987 Feb 01; 47(3):747-53. PubMed ID: 3802079 [Abstract] [Full Text] [Related]
13. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells. Lee AW, Oates PS, Trinder D. Hepatology; 2003 Oct 01; 38(4):967-77. PubMed ID: 14512884 [Abstract] [Full Text] [Related]
14. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD, Baker-Cairns BJ, Friden PM, Oliver C, Villegas JC. Exp Neurol; 1996 Nov 01; 142(1):47-65. PubMed ID: 8912898 [Abstract] [Full Text] [Related]
15. Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence. Aloj L, Jogoda E, Lang L, Caracò C, Neumann RD, Sung C, Eckelman WC. J Nucl Med; 1999 Sep 01; 40(9):1547-55. PubMed ID: 10492378 [Abstract] [Full Text] [Related]
16. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake. Richardson DR, Baker E. J Cell Physiol; 1994 Oct 01; 161(1):160-8. PubMed ID: 7929602 [Abstract] [Full Text] [Related]
17. Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cells. Rhyner K, Taetle R, Bering H, To D. J Cell Physiol; 1985 Dec 01; 125(3):608-12. PubMed ID: 2999167 [Abstract] [Full Text] [Related]
18. Differential growth-inhibitory effects of gallium on B-lymphocyte lines in high versus low iron concentrations. Kovar J, Seligman P, Gelfand EW. Cancer Res; 1990 Sep 15; 50(18):5727-30. PubMed ID: 2393846 [Abstract] [Full Text] [Related]
19. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Masui H, Kawamoto T, Sato JD, Wolf B, Sato G, Mendelsohn J. Cancer Res; 1984 Mar 15; 44(3):1002-7. PubMed ID: 6318979 [Abstract] [Full Text] [Related]
20. [Interrelation between transferrin receptor expression and intracellular ferritin concentration in leukemia cells and normal marrow cells]. Rhyner K, Taetle R. Schweiz Med Wochenschr; 1986 Oct 25; 116(43):1484-7. PubMed ID: 3787230 [Abstract] [Full Text] [Related] Page: [Next] [New Search]